HBeAg-话题@MedSci

#HBeAg#

30篇内容 | 2240人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1368957, encodeId=5fc1136895e2e, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……, objectType=article, longId=132313, objectId=bb6013231302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb6013231302, replyNumber=0, likeNumber=65, createdTime=2018-03-15, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb6013231302, moduleTitle=Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb6013231302)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368956, encodeId=5f1e13689560a, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型, objectType=article, longId=132044, objectId=d3a81320444c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a81320444c, replyNumber=0, likeNumber=88, createdTime=2018-03-12, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a81320444c, moduleTitle=J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a81320444c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368955, encodeId=33151368955bb, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatol Res：在HBeAg阳性母亲中，病毒载量是母婴传播风险的一个重要危险因素, objectType=article, longId=130742, objectId=f1af130e425f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1af130e425f, replyNumber=0, likeNumber=76, createdTime=2018-02-28, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1af130e425f, moduleTitle=Hepatol Res：在HBeAg阳性母亲中，病毒载量是母婴传播风险的一个重要危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1af130e425f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368954, encodeId=51d01368954fc, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Cell Mol Life Sci：HBeAg通过诱导巨噬细胞miR-155的表达，加速肝脏损伤, objectType=article, longId=127179, objectId=bbf512e17938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbf512e17938, replyNumber=0, likeNumber=61, createdTime=2018-01-23, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbf512e17938, moduleTitle=Cell Mol Life Sci：HBeAg通过诱导巨噬细胞miR-155的表达，加速肝脏损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbf512e17938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368953, encodeId=350413689533b, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Viral Hepat ：GPR预测HBeAg阳性和阴性患者肝纤维化程度方面，优于APRI和FIB-4这两个指标, objectType=article, longId=123371, objectId=027f1233e1b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=027f1233e1b9, replyNumber=0, likeNumber=72, createdTime=2017-12-15, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=027f1233e1b9, moduleTitle=J Viral Hepat ：GPR预测HBeAg阳性和阴性患者肝纤维化程度方面，优于APRI和FIB-4这两个指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=027f1233e1b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368952, encodeId=3b6d13689522f, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率, objectType=article, longId=122123, objectId=30d7122123c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30d7122123c6, replyNumber=0, likeNumber=64, createdTime=2017-12-04, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30d7122123c6, moduleTitle=J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30d7122123c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368951, encodeId=dde5136895197, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Hepatol：无肝纤维化HBeAg阴性患者能停用替诺福韦酯吗？, objectType=article, longId=121696, objectId=faae121696bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faae121696bb, replyNumber=0, likeNumber=76, createdTime=2017-11-30, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faae121696bb, moduleTitle=J Hepatol：无肝纤维化HBeAg阴性患者能停用替诺福韦酯吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faae121696bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368950, encodeId=4d67136895048, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Genet Mol Res：乙肝HBeAg和Anti-HBeAb同时阳性可能吗？, objectType=article, longId=116153, objectId=c798116153c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c798116153c5, replyNumber=0, likeNumber=67, createdTime=2017-10-15, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c798116153c5, moduleTitle=J Genet Mol Res：乙肝HBeAg和Anti-HBeAb同时阳性可能吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c798116153c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368949, encodeId=8d201368949ff, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发, objectType=article, longId=112444, objectId=1e7611244454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7611244454, replyNumber=0, likeNumber=62, createdTime=2017-09-10, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7611244454, moduleTitle=Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7611244454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368948, encodeId=d16213689487c, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatology：肠道菌群移植，HBeAg持续阳性患者的福音, objectType=article, longId=92684, objectId=52279268487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52279268487, replyNumber=0, likeNumber=68, createdTime=2017-03-22, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52279268487, moduleTitle=Hepatology：肠道菌群移植，HBeAg持续阳性患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52279268487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368947, encodeId=f7a0136894ea6, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatology：word天！粪便菌群移植能够诱导HBeAg阳性患者HBeAg清除, objectType=article, longId=86076, objectId=0d9b860e65b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d9b860e65b, replyNumber=0, likeNumber=62, createdTime=2016-12-31, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d9b860e65b, moduleTitle=Hepatology：word天！粪便菌群移植能够诱导HBeAg阳性患者HBeAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d9b860e65b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368946, encodeId=307b136894625, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好, objectType=article, longId=70400, objectId=e9bae04003f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9bae04003f, replyNumber=0, likeNumber=73, createdTime=2016-06-11, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9bae04003f, moduleTitle=PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9bae04003f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368945, encodeId=764b1368945a3, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Gut：HBcAb定量可强烈预测HBeAg血清学转换率, objectType=article, longId=45553, objectId=0737455534e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0737455534e, replyNumber=0, likeNumber=61, createdTime=2015-01-17, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0737455534e, moduleTitle=Gut：HBcAb定量可强烈预测HBeAg血清学转换率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0737455534e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368944, encodeId=635a1368944e6, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Journal of Hepatology：基因型特异性HBsAg动力学可指导HBeAg(-)慢性乙肝患者的治疗, objectType=article, longId=22616, objectId=ec01226163e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec01226163e, replyNumber=0, likeNumber=119, createdTime=2013-08-07, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec01226163e, moduleTitle=Journal of Hepatology：基因型特异性HBsAg动力学可指导HBeAg(-)慢性乙肝患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec01226163e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368943, encodeId=140f136894355, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准, objectType=article, longId=21388, objectId=c01b2138812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01b2138812, replyNumber=0, likeNumber=69, createdTime=2013-07-15, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01b2138812, moduleTitle=Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c01b2138812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368942, encodeId=d2c813689421d, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Gastroenterology：HBeAg阳性母亲的子女更易发生突破性乙肝, objectType=article, longId=4749, objectId=d93c4e499a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d93c4e499a, replyNumber=0, likeNumber=70, createdTime=2012-04-12, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d93c4e499a, moduleTitle=Gastroenterology：HBeAg阳性母亲的子女更易发生突破性乙肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d93c4e499a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBeAg

2020-05-29

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……

2018-03-15

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型

2018-03-12

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatol Res：在HBeAg阳性母亲中，病毒载量是母婴传播风险的一个重要危险因素

2018-02-28

仁医06 (审核中...)

前往app查看评论内容

#HBeAg#

Cell Mol Life Sci：HBeAg通过诱导巨噬细胞miR-155的表达，加速肝脏损伤

2018-01-23

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Viral Hepat ：GPR预测HBeAg阳性和阴性患者肝纤维化程度方面，优于APRI和FIB-4这两个指标

2017-12-15

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率

2017-12-04

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Hepatol：无肝纤维化HBeAg阴性患者能停用替诺福韦酯吗？

2017-11-30

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Genet Mol Res：乙肝HBeAg和Anti-HBeAb同时阳性可能吗？

2017-10-15

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发

2017-09-10

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatology：肠道菌群移植，HBeAg持续阳性患者的福音

2017-03-22

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatology：word天！粪便菌群移植能够诱导HBeAg阳性患者HBeAg清除

2016-12-31

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好

2016-06-11

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Gut：HBcAb定量可强烈预测HBeAg血清学转换率

2015-01-17

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Journal of Hepatology：基因型特异性HBsAg动力学可指导HBeAg(-)慢性乙肝患者的治疗

2013-08-07

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准

2013-07-15

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Gastroenterology：HBeAg阳性母亲的子女更易发生突破性乙肝

2012-04-12

科室
- - 订阅+
  - 更多科室
工具
服务